HOME >> BIOLOGY >> NEWS
HIV-1 Levels In Semen Don't Correspond To Viral Levels In Blood, Say Pitt,,Researchers In A Report At 12th World AIDS Conference

PITTSBURGH, Penn., June 25--Current testing practices, which typically measure the viral load or the amount of freely circulating genetic material of HIV-1 in the blood, may not accurately detect the amount of virus in semen, say researchers from the University of Pittsburgh Graduate School of Public Health (GSPH).

In a report presented on June 30 at the 12th World AIDS Conference, Pitt researcher, Phalguni Gupta, Ph.D., emphasized that testing viral load levels in semen as well as targeting treatments to sites of seminal virus production may offer physicians a better way to monitor viral activity in HIV-infected patients and also stem transmission of HIV-1.

"To accurately assess how easily and how much HIV can be transmitted during risky sexual contact with HIV-infected individuals, we can't rely on blood tests. Instead, we need to test viral load levels in semen," said Dr. Gupta, who is a professor of infectious diseases and microbiology at Pitt's GSPH.

"Most of the HIV-infected men in our study had very high levels of virus present in their semen at certain time points and then at other times had a lower amount. This indicates that some men may be more likely to transmit the virus during risky sexual behaviors at certain times."

Dr. Gupta and his colleagues are the first to report HIV in semen can fluctuate greatly in some HIV-infected men and does not correspond to viral levels in blood. A previous study by the Pitt group found differences between the types of HIV found in the blood and semen of some HIV-infected men.

"These results, taken together with our new findings, indicate that virus found in the semen originates from a separate site, different from that of virus that circulates throughout the body." remarked Dr. Gupta. "If we locate the site where seminal virus is produced, we may be able to target treatments to this site and suppress replication of viral strains which may be different than
'"/>

Contact: Amy Kemp
kempam@a1.isd.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
30-Jun-1998


Page: 1 2 3

Related biology news :

1. Scientists discover proteins involved in spread of HIV-1 infection
2. Dana-Farber scientists discover natural blocker of HIV-1 virus
3. Kissing RNA and HIV-1: Unraveling the details
4. Can a universal HIV-1 vaccine be developed? AIDScience.com describes current research strategies
5. Human genome bears a virus related to HIV-1
6. Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses
7. NIAID-Supported Scientists Discover Origin Of HIV-1
8. Major New Study Shows HIV-1 Antibodies Found In Urine
9. Boosting Immune Response Against HIV-1 Key To Controlling Infection, Say University Of Pittsburgh Researchers
10. The Reason The French Have Low Levels Of Heart Disease
11. Marine Life In South Pacific Region Found To Be Impervious To Oceans Highest Arsenic Levels

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... -- Symic Bio, a biopharmaceutical company focused on matrix ... announced today the completion of enrollment for the SHIELD ... trial will evaluate the safety and efficacy of SB-030, ... restenosis following angioplasty. "We,re pleased to ... Nathan Bachtell , M.D., Chief Medical Officer of ...
(Date:2/24/2017)... ... , ... FireflySci, Inc is an explosive small business that continues to grow ... bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy world. ... on as they add yet another mark on the global map. , With distributors ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
Breaking Biology Technology:
Cached News: